despite neutral imaging results, adalimumab did improve other key markers of inflammation in the blood including glyca, crp, tnf, and il-6. .
he said: "greater and immediate attention needs to be applied in these two areas." . .
OFF DEAL
OFF DEAL
181 Used Today
OFF DEAL